Skip to Main content Skip to Navigation
Journal articles

Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.

Abstract : Airway-centered interstitial fibrosis (ACIF) is a distinct type of lung interstitial fibrosis characterized by lesions centered on the airways. Several cases reported in the literature showed little to no effect of corticosteroids and a high mortality rate in the absence of lung transplantation. No other efficient approach is described for the treatment of this type of fibrosis. We report for the first time the case of a 44-year-old patient diagnosed with ACIF on surgical lung biopsy and stabilized with clarithromycin after failure of systemic corticosteroids. We need to confirm this benefit in other patients to ascertain the anti-inflammatory effect of macrolides, which are far less harmful compared to corticosteroids or immunosuppressant drugs.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00872810
Contributor : Morgane Le Corre <>
Submitted on : Monday, October 14, 2013 - 2:40:32 PM
Last modification on : Wednesday, May 16, 2018 - 11:24:07 AM

Links full text

Identifiers

Citation

Stéphane Jouneau, M. Kerjouan, S. Caulet-Maugendre, S. Guillot, C. Meunier, et al.. Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.. Respiration, Karger, 2013, 85 (2), pp.156-9. ⟨10.1159/000341982⟩. ⟨inserm-00872810⟩

Share

Metrics

Record views

556